Inhibition of the Grb2 expression in mice via liposomal antisense oligodeoxynucleotide DOPC liposomes has shown decreased tumor growth (0.29 g ± 0.14 g, p < 0.05) and a greater decrease in tumor weight when treated in combination with Paclitaxel (0.82 g ± 0.25 g, p < 0.05) [55]. This evidence concerns the gene GRB2 and neoplasm.